4 Biotech Stocks With Bright Prospects To Buy Amid Recovery

New drug approvals, acquisitions, and other pipeline developments are back in the spotlight in the biotech industry, following the focus on the development of vaccines and antibody treatments for COVID-19 in the last two years.